Stay updated on TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Sign up to get notified when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.

Latest updates to the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the prior revision v3.4.1 was removed.SummaryDifference0.1%

- Check19 days agoChange DetectedA new revision entry v3.4.1 was added to the history, and the previous revision v3.4.0 was removed.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page history shows a new revision entry v3.4.1 added and an older revision v3.4.0 removed, indicating a minor backend/site update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedLatest version adds Contacts/Locations and updates the Study Status in the study record; a prior version shows a deletion dated 2026-01-13.SummaryDifference0.5%

- Check41 days agoChange DetectedOn 2026-01-13, new entries for Contacts/Locations and Study Status were added (Revision: v3.3.4). The prior revision (v3.3.3) was removed on 2024-12-19.SummaryDifference0.6%

- Check62 days agoChange DetectedThe page now shows a new revision entry for NCT05156983 (v3.3.3) in the study history. The footer no longer lists the HHS Vulnerability Disclosure link and the v3.3.2 revision.SummaryDifference0.2%

Stay in the know with updates to TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.